The new entity features other labels owned by Authentic Brands Group and run by Sparc Group. Investors include Shein and mall ...
March 2024: Moleac Pte Ltd announced a study of Phase 4 clinical trials for NeuroAiD. SATURN investigates the promising role ...
According to DelveInsight's analysis, the mild cognitive impairment market is anticipated to increase during the forecast period (2024-2034), owing to the rise in the launch of emerging therapies ...
DelveInsight's Mild Cognitive Impairment Market Insights report includes a comprehensive understanding of current treatment ...